Who sues the leadership of biotech companies
Every raise is a set of representations investors can revisit after a miss; down rounds convert enthusiasm into allegations.
Trial-readout communications, partnership terminations, and pivot decisions each generate the sector’s claims — aimed at directors who approved language and timing.
How D&O fits with EPL, cyber and fiduciary coverage
EPLI attaches for RIF and equity-dispute claims; fiduciary follows the 401(k). See our biotech management liability guide for the workforce side. See our full biotech companies management liability guide for the employment-practices side of the program. Explore D&O insurance, cyber liability, and fiduciary liability, or start with employment practices liability.
What a claim can look like
A bridge round at a sharp discount follows a delayed readout; prior-round investors allege timeline misrepresentation, naming the CEO and board.
A partnered program’s termination triggers milestone-payment disputes and shareholder claims the board favored the partner relationship over disclosure.
Scenarios are illustrative composites, not descriptions of actual claims or outcomes. Whether any claim is covered depends on the policy issued.
What carriers will ask about your organization
- Stage, cap table, and financing history
- Upcoming raise and readout timeline
- Board composition — investor directors
- Communication-review practices
- Claims history
- Funding and payroll
We market your account and you compare terms side by side — no obligation.
Get Multiple Quotes within minutesFrequently asked questions
- When exactly should D&O bind?
- Before the round prices — term sheets commonly require it at close, and negotiations deserve its protection.
- What limits do biotech boards expect?
- Stage-benchmarked, rising with each round; we place against life-science comparables, not generic tech tables.
- Are regulatory communications covered?
- Securities-adjacent claims are the form’s core; investigation triggers vary and we negotiate them for the sector.
- IPO horizon — impact?
- Public-company towers restructure everything; we build the private program to convert cleanly.
Provident Financial Group is an independent insurance agency, not a carrier. We place coverage for biotech companies in New Jersey, New York, Connecticut, Vermont, Ohio, Pennsylvania, Michigan, Kansas, North Carolina, South Carolina, the District of Columbia, Virginia, Maryland, Delaware, Georgia, Florida, Texas, California, Kentucky, Massachusetts, Indiana, Nevada, and Arizona.